T 0469/23 (Oral azacytidine II/CELGENE) of 03.06.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T046923.20250603
- Date of decision
- 3 June 2025
- Case number
- T 0469/23
- Petition for review of
- -
- Application number
- 13182721.4
- IPC class
- A61K 31/7068A61K 9/20A61K 9/28
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Oral formulations of cytidine analogs and methods of use thereof
- Applicant name
- Celgene Corporation
- Opponent name
- Generics (U.K.) Limited
Teva Pharmaceutical Industries Ltd.
Hoffmann Eitle
Sandoz AG - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 76(1)European Patent Convention Art 84Guidelines_F-IV 4(7)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Amendments - added subject-matter (yes)
Claims - clarity
Claims - auxiliary request (no)
Late-filed request - should have been submitted in first-instance proceedings (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed